RxDoctor Payments Data

Stephanie Donovan, DPM

Podiatrist · Plymouth, MINPI 1992095467

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,512 of the $8,370 with a category attached, or 65.9%. It is spread thinly across 18 manufacturers, the largest accounting for just 17.7%. Reporting peaked in 2022 at $3,512 and has fallen 60.0% since, to $1,406 in 2025.

$8,370in general payments, 2019–2025

Across 71 payments — averaging $117.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$1K
  • Osteomed LLC$1K
  • Integra Lifesciences Corporation$1K
  • Treace Medical Concepts, Inc.$867
  • Kerecis Limited$845
  • Stryker$760
  • plus $2K from 12 others

What the payments were for

  • Travel & lodging$1,20814%
  • Food & beverage$5,51266%
  • Education$1,65020%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,370 in reported general payments places this provider in the 85th percentile of 302 podiatrist providers in Michigan.

See all podiatrist providers in Michigan

Medicare billing

Part B allowed, 2024
$107,419
Medicare patients
455
Services billed
1,264

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate84$1,910
Ketoconazole61$1,283
Econazole Nitrate34$798
Triamcinolone Acetonide49$490
Doxycycline Hyclate43$248
Meloxicam61$163
Ciprofloxacin Hcl13$84
Cephalexin15$83
Methylprednisolone13$68
Gabapentin13$62

Paid to pharmacies, not to this prescriber.

Other podiatrist in Plymouth

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →